TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Xxlofoten AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,484
|
2,278
|
1,567 |
Financial expenses |
38
|
30
|
40 |
Earnings before taxes |
453
|
438
![]() |
438 |
Total assets |
1,885
|
2,468
|
2,211 |
Current assets |
969
|
1,223
|
1,022 |
Current liabilities |
683
|
166
|
185 |
Equity capital |
579
|
1,578
|
1,240 |
- share capital |
330
|
352
|
372 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
30.7%
|
63.9%
|
56.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
18.2%
|
19.2%
|
28.0% |
Return on assets (ROA) |
26.0%
|
19.0%
|
21.6% |
Current ratio |
141.9%
|
736.7%
|
552.4% |
Return on equity (ROE) |
78.2%
|
27.8%
|
35.3% |
Change turnover |
351
|
793
|
633 |
Change turnover % |
16%
|
53%
|
68% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.